Results 261 to 270 of about 104,894 (342)
Dextran sodium sulfate confounds causal role of periodontitis in inflammatory bowel disease
Abstract Background Emerging evidence supports a bidirectional link between periodontitis and inflammatory bowel disease (IBD). To investigate this relationship, experimental models commonly use dextran sodium sulfate (DSS) to induce colitis. However, DSS is presumed to selectively affect the colon, and its potential off‐target effects on the oral ...
Himanshi Tanwar +11 more
wiley +1 more source
Evaluating MRI response criteria in microsatellite instability-high rectal cancer treated with immune checkpoint inhibitors. [PDF]
Vanderbecq Q +6 more
europepmc +1 more source
Abstract Children with inflammatory bowel diseases (IBD) have limited access to the available advanced therapies, given the lengthy gap between adult and pediatric approval. We aimed to review key hurdles for pediatric trials and recommend practical solutions.
Dan Turner +21 more
wiley +1 more source
Gastrointestinal stromal tumor of the rectum mimicking a prostatic mass: case report. [PDF]
El Hajjami A +4 more
europepmc +1 more source
Real‐world data on STRIDE‐II treatment targets in a pediatric cohort with inflammatory bowel disease
Abstract Objectives STRIDE (selecting therapeutic targets in inflammatory bowel disease) established evidence‐based targets for treat‐to‐target strategies in IBD. STRIDE‐II designates clinical remission, C‐reactive protein (CRP) normalization, and fecal calprotectin (FC) reduction as short‐ to intermediate‐term targets, and mucosal healing as a long ...
Marie‐Luise Frank +9 more
wiley +1 more source
Perioperative utilization of JAK inhibitors in Perianal Fistulizing Crohn's disease
Abstract With the recent approval of small molecule drugs such as upadacitinib in adult inflammatory bowel disease (IBD), their utilization is becoming more common; however, there is limited data on perioperative risks or optimal timing of cessation and resumption to mitigate flares. Current recommendations suggest holding these medications for 14 days
Alexander Lyons +2 more
wiley +1 more source
Successful Management of Recurrent Rectal Leiomyosarcoma: A Case Report. [PDF]
Butare A, Akram W.
europepmc +1 more source
Abstract While endoscopic remission is an important target in pediatric Crohn's disease (CD), no consensus for restaging timing exists. This retrospective cohort study assessed the timing and impact of restaging endoscopy in children with new CD in remission, comparing earlier ( ≤ 9 months) versus later endoscopy.
Anna Janecek +7 more
wiley +1 more source
Fournier's gangrene as initial presentation of rectal cancer. [PDF]
Sánchez Iglesias S +2 more
europepmc +1 more source

